Dynamic Insulin on Board: Incorporation of Circadian Insulin Sensitivity Variation
Динамический активный инсулин: учет циркадной вариабельности чувствительности к инсулину
2013-07-01
SCID: 54.1/dqumd6ry
Discuss with AI
artificial pancreascircadian insulin sensitivitycontinuous subcutaneous insulin infusiondynamic insulin-on-boardhypoglycemia
Figures from the paper
Abstract (AI)
BACKGROUND: Insulin-on-board (IOB) estimation is used in modern insulin therapy with continuous subcutaneous insulin infusion (CSII) as well as different automatic glucose-regulating strategies (i.e., artificial pancreas products) to prevent insulin stacking that may lead to hypoglycemia. However, most of the IOB calculations are static IOB (sIOB): they are based only on approximated insulin decay and do not take into account diurnal changes in insulin sensitivity. METHODS: A dynamic IOB (dIOB) that takes into account diurnal insulin sensitivity variation is suggested in this work and used to adjust the sIOB estimations. The dIOB function is used to correct the dosage of insulin boluses in light of this circadian variation. RESULTS: Basal-bolus as applied by pump users and model predictive control therapy with and without dIOB were evaluated using the University of Virginia/Padova metabolic simulator. Three protocols with four meals of 1 g carbohydrate/kg body weight were evaluated: a nominal scenario and two robustness scenarios, one in which insulin sensitivity was 15% greater than estimated and the other where the lunch is 30% less than announced. In the nominal and robustness scenarios, respectively, the dIOB led to 6% and 24% and 40% less hypoglycemia episodes than approaches without IOB. The new approach was also compared with the sIOB to evaluate the improvements with respect to the previous approach. CONCLUSIONS: Improved glucose regulation was demonstrated using the dIOB where circadian insulin sensitivity is used to adjust IOB estimation. Use of diurnal variations of insulin sensitivity appears to promote effective and safe insulin therapy using CSII or artificial pancreas. Clinical trials are warranted to determine whether nocturnal hypoglycemia can be reduced using the dIOB approach.
Key Findings
1
A dynamic insulin-on-board (dIOB) method incorporates diurnal insulin sensitivity variation into conventional insulin-on-board estimates.
2
Clinical trials are needed to determine whether dIOB can reduce nocturnal hypoglycemia in practice.
3
In University of Virginia/Padova simulator testing, dIOB reduced hypoglycemia episodes by 6% in the nominal scenario and 24% and 40% in two robustness scenarios compared with approaches without IOB.
4
The dIOB approach adjusts insulin bolus dosing to account for circadian changes in insulin sensitivity and reduce insulin stacking risk.
5
dIOB improved glucose regulation in simulated basal-bolus pump therapy and model predictive control compared with static IOB-based approaches.
Research Object
Insulin-on-board estimation and insulin dosing in CSII and artificial pancreas glucose-regulation systems
Research Subject
The effect of incorporating circadian insulin-sensitivity variation into dynamic IOB estimation on insulin bolus adjustment, glucose regulation, and hypoglycemia
Publication Details
Publication Date
2013-07-01
Journal
Journal of Diabetes Science and Technology
Publisher
SAGE Publishing
ISSN
1932-2968
Cited by
76
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
Cited by4
Circadian Variability of Insulin Sensitivity: Physiological Input for In Silico Artificial Pancreas2014
Adaptive Zone Model Predictive Control of Artificial Pancreas Based on Glucose- and Velocity-Dependent Control Penalties2018
Intra-patient dynamic variations in Type 1 Diabetes: A review2016
Zone Model Predictive Control with Glucose- and Velocity-Dependent Control Penalty Adaptation for an Artificial Pancreas2018